# Glutamine Supplementation in People With Immune Dysregulation

> **NCT04019769** · EARLY_PHASE1 · WITHDRAWN · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)**

## Conditions studied

- Eczema
- MTOROC1 Signaling

## Interventions

- **DRUG:** L-glutamine

## Key facts

- **NCT ID:** NCT04019769
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-03-12
- **Primary completion:** 2021-01-01
- **Final completion:** 2021-01-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI left NIH. No subjects enrolled.
- **Last updated:** 2020-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04019769

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04019769, "Glutamine Supplementation in People With Immune Dysregulation". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04019769. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*